Growth, Trends and Report Highlights

According to a new report Global Polymerase Chain Reaction Technologies Market, published by KBV research, The Global Polymerase Chain Reaction Technologies Market size is expected to reach $11.5 billion by 2024, rising at a market growth of 6.2% CAGR during the forecast period.

The North America market would dominate the Global Real-Time PCR Market by Region by 2024, growing at a CAGR of 4.4 % during the forecast period. The Europe market is expected to witness a CAGR of 5.4% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 6.2% during (2018 - 2024).

The Forensics market dominated the Global Polymerase Chain Reaction Technologies Market by Application in 2017. The Research market is expected to witness a CAGR of 6.8% during (2018 - 2024). Additionally, The Clinical market is expected to witness highest CAGR of 6% during (2018 - 2024).

The Reagents & Consumables market dominated the Global Polymerase Chain Reaction Technologies Market by Product in 2017, and would achieve a market value of $4,631.4 million by 2024. The Services market is expected to witness a CAGR of 7.9% during (2018 - 2024). The Instruments market is expected to witness a CAGR of 6% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/polymerase-chain-reaction-technologies-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.

Global Polymerase Chain Reaction Technologies Market Segmentation

By Technology

• Real-time PCR
• Digital PCR
• Traditional PCR

By Application

• Forensics
• Research
• Clinical

By Product

• Instruments
• Reagents & Consumables
• Software
• Services

By End User

• Biotech & Pharma Company
• Diagnostics Centers & Hospitals
• Academic & Research Institutions

 By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Agilent Technologies
• BioMérieux
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd
• Fluidigm Corporation
• LGC Limited
• Qiagen NV
• SYGNIS Pharma AG
• Takara Bio, Inc.
• Thermo Fisher Scientific

Unique Offerings from KBV Research

• Exhaustive coverage  
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Polymerase Chain Reaction Technologies Market (2018-2024)

Europe Polymerase Chain Reaction Technologies Market (2018-2024)

Asia Pacific Polymerase Chain Reaction Technologies Market (2018-2024)

LAMEA Polymerase Chain Reaction Technologies Market (2018-2024)